Bringing Chinese innovation to global stage

Roche aiming to develop medicines 'in China for China and the world'

Swiss pharmaceutical giant Roche Group - which established the first foreign-funded research and development center in Shanghai in 2004 and was the first multinational enterprise in Shanghai Zhangjiang Hi-Tech Park in 1994 - announced the completion of a new innovation center in the city on Oct 21.

Representing an investment of 863 million yuan ($122 million), the innovation center focuses on research and early development of innovative drugs for immunology, inflammation and infectious diseases, and will further bring China's R&D to the world stage by developing innovative drugs to meet patients' unmet needs.